<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37330018</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>387</Volume><PubDate><Year>2023</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Predictive value of ASCVD risk score for mortality and major adverse cardiovascular events in the year following a COVID-19 infection among US Veterans.</ArticleTitle><Pagination><StartPage>131120</StartPage><MedlinePgn>131120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">131120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2023.131120</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(23)00927-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Morbidity and mortality following COVID-19 infection may be influenced by baseline atherosclerotic cardiovascular disease (ASCVD) risk, yet limited data are available to identify those at highest risk. We examined the association between baseline ASCVD risk with mortality and major adverse cardiovascular events (MACE) in the year following COVID-19 infection.</AbstractText><AbstractText Label="METHODS">We evaluated a nationwide retrospective cohort of US Veterans free of ASCVD who were tested for COVID-19. The primary outcome was absolute risk of all-cause mortality in the year following a COVID-19 test among those hospitalized vs. not stratified by baseline VA-ASCVD risk scores. Secondarily, risk of MACE was examined.</AbstractText><AbstractText Label="RESULTS">There were 393,683 Veterans tested for COVID-19 and 72,840 tested positive. Mean age was 57&#xa0;years, 86% were male, and 68% were white. Within 30&#xa0;days following infection, hospitalized Veterans with VA-ASCVD scores &gt;20% had an absolute risk of death of 24.6% vs. 9.7% (P&#xa0;&#x2264;0.0001) for those who tested positive and negative for COVID-19 respectively. In the year following infection, risk of mortality attenuated with no difference in risk after 60&#xa0;days. The absolute risk of MACE was similar for Veterans who tested positive or negative for COVID-19.</AbstractText><AbstractText Label="CONCLUSIONS">Veterans without clinical ASCVD experienced an increased absolute risk of death within 30&#xa0;days of a COVID-19 infection compared to Veterans with the same VA-ASCVD risk score who tested negative, but this risk attenuated after 60&#xa0;days. Whether cardiovascular preventive medications can lower the risk of mortality and MACE in the acute period following COVID-19 infection should be evaluated.</AbstractText><CopyrightInformation>Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guardino</LastName><ForeName>Eric T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA; Division of Aging, Brigham &amp; Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA. Electronic address: eguardino@une.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarko</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Peter W F</ForeName><Initials>PWF</Initials><AffiliationInfo><Affiliation>Atlanta VA Healthcare System, 1670 Clairmont Road, Decatur, GA 30033, USA; Emory Clinical Cardiology Research Institute, 1462 Clifton Rd NE, 5(th) Floor, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaziano</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA; Division of Aging, Brigham &amp; Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA; Boston University School of Public Health, Department of Biostatistics, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orkaby</LastName><ForeName>Ariela R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 2 2 Avenue de Lafayette, Boston, MA 02111, USA; Division of Aging, Brigham &amp; Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA; New England GRECC (Geriatric Research, Education, and Clinical Center) VA Boston Healthcare System, 150 S Huntington St, Boston, MA 02130, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 CX001025</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="Y">Atherosclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ASCVD risk score</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">US Veterans</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest No authors have any conflicts of interest for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>18</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37330018</ArticleId><ArticleId IdType="pmc">PMC10270727</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2023.131120</ArticleId><ArticleId IdType="pii">S0167-5273(23)00927-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Modin D., Claggett B., Sindet-Pedersen C., et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circ N Y N. 2020;142(21):2080&#x2013;2082. doi: 10.1161/CIRCULATIONAHA.120.050809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050809</ArticleId><ArticleId IdType="pmc">PMC7682795</ArticleId><ArticleId IdType="pubmed">33054349</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022 doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez S.E., Sylling P.W., Mor M.K., et al. Developing an algorithm for combining race and ethnicity data sources in the veterans health administration. Mil. Med. 2020;185(3&#x2013;4):e495&#x2013;e500. doi: 10.1093/milmed/usz322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/usz322</ArticleId><ArticleId IdType="pubmed">31603222</ArticleId></ArticleIdList></Reference><Reference><Citation>Turano A., Eibling D. Using Voogle to search within patient records in the VA corporate data warehouse. Fed. Pract. 2019;36(11):518&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913608</ArticleId><ArticleId IdType="pubmed">31892775</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassy J.L., Lu B., Ho Y.L., et al. Estimation of atherosclerotic cardiovascular disease risk among patients in the veterans affairs health care system. JAMA Netw. Open. 2020;3(7):e208236. doi: 10.1001/jamanetworkopen.2020.8236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.8236</ArticleId><ArticleId IdType="pmc">PMC7361654</ArticleId><ArticleId IdType="pubmed">32662843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman A., Peterson K., Turano A., Box T., Wallace K., Jones M. A Natural Language Processing System for National COVID-19 Surveillance in the US Department of Veterans Affairs; Proceedings of the 1st Workshop on NLP for COVID-19 at ACL 2020; 2020.</Citation></Reference><Reference><Citation>Song R.J., Ho Y.L., Nguyen X.M.T., et al. Abstract 18809: development of an electronic health record-based algorithm for smoking status using the million veteran program (MVP) cohort survey response. Circ N Y N. 2016;134(Suppl. 1):A18809.</Citation></Reference><Reference><Citation>Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circ N Y N. 2014;129(25_suppl_2 Suppl 1):S49&#x2013;S73. doi: 10.1161/01.cir.0000437741.48606.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000437741.48606.98</ArticleId><ArticleId IdType="pubmed">24222018</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy S.M., Stone N.J., Bailey A.L., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circ N Y N. 2019;139(25):e1082&#x2013;e1143. doi: 10.1161/CIR.0000000000000625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000625</ArticleId><ArticleId IdType="pmc">PMC7403606</ArticleId><ArticleId IdType="pubmed">30586774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mafham M.M., Spata E., Goldacre R., et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet Br. bv. Ed. 2020;396(10248):381&#x2013;389. doi: 10.1016/S0140-6736(20)31356-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31356-8</ArticleId><ArticleId IdType="pmc">PMC7429983</ArticleId><ArticleId IdType="pubmed">32679111</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart K.A., Blue L., Kranker K., et al. Hospital use for myocardial infarction and stroke among Medicare beneficiaries from march to December 2020. JAMA Cardiol. 2021;6(11):1340&#x2013;1342. doi: 10.1001/jamacardio.2021.2729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2729</ArticleId><ArticleId IdType="pmc">PMC8339994</ArticleId><ArticleId IdType="pubmed">34347009</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin P.C. Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes. J. Clin. Epidemiol. 2010;63(1):46&#x2013;55. doi: 10.1016/j.jclinepi.2009.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.03.012</ArticleId><ArticleId IdType="pubmed">19595575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53(282):457&#x2013;481. doi: 10.2307/2281868.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2281868</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z., Cooper J., Salih A., et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart Br. Card. Soc. October 24, 2022 doi: 10.1136/heartjnl-2022-321492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2022-321492</ArticleId><ArticleId IdType="pmc">PMC9811071</ArticleId><ArticleId IdType="pubmed">36280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang C.Y., Wang S.I., Wei J.C.C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619. doi: 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101619</ArticleId><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020;17(9):543&#x2013;558. doi: 10.1038/s41569-020-0413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Yaliu, Yan Mengwen. Mechanisms of cardiovascular system injury induced by COVID-19 in elderly patients with cardiovascular history. Front. Cardiovasc. Med. 2022:9. doi: 10.3389/fcvm.2022.859505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.859505</ArticleId><ArticleId IdType="pmc">PMC9116509</ArticleId><ArticleId IdType="pubmed">35600485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., et al. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin. Microbiol. Infect. 2021;27(9):1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers K.D., Wilemon K., McGowan M.P., Howard W., Staszak D., Rader D.J. COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD. Am. J. Prev. Cardiol. 2021;7:100197. doi: 10.1016/j.ajpc.2021.100197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpc.2021.100197</ArticleId><ArticleId IdType="pmc">PMC8387291</ArticleId><ArticleId IdType="pubmed">34611637</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhamis A., Alshamali Y., Chehadeh W., et al. Predictors of intensive care unit admission and mortality in SARS-CoV-2 infection: a cross sectional study at a tertiary care hospital. Ann. Med. Surg. 2012;2022(80) doi: 10.1016/j.amsu.2022.104097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104097</ArticleId><ArticleId IdType="pmc">PMC9259005</ArticleId><ArticleId IdType="pubmed">35818560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>